Table 2.

Characteristics of IV plerixafor-mobilized apheresis products, phase 2

Characteristic	Mean (range)
Viability of product, %	93 (87-99)
Length of product storage, d	24 (6-241)
Peak mobilized CD34/μL, phase 1	28.7 (7-157)
Peak mobilized CD34/μL, phase 2	18.6 (4-46)
Total no. CD34 collected day 1 × 108	2.1 (0.5-6.6)
Pheresis volume day 1, L	17.91 (3.7-20)
No. CD3 × 108/kg recipient weight	5.25 (1.98-10)
No. CD34 × 106/kg recipient weight	2.9 × 106 (2.0-9.7 × 106)